These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37293165)

  • 1. Activation of the IL-17 signalling pathway by the CXCL17-GPR35 axis affects drug resistance and colorectal cancer tumorigenesis.
    Bu J; Yan W; Huang Y; Lin K
    Am J Cancer Res; 2023; 13(5):2172-2187. PubMed ID: 37293165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells.
    Wang Z; Liu J; Yang T; Wang Q; Liang R; Tang J
    Mol Cell Biochem; 2023 May; 478(5):1045-1057. PubMed ID: 36219357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.
    Binti Mohd Amir NAS; Mackenzie AE; Jenkins L; Boustani K; Hillier MC; Tsuchiya T; Milligan G; Pease JE
    J Immunol; 2018 Jul; 201(2):714-724. PubMed ID: 29875152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
    Park SJ; Lee SJ; Nam SY; Im DS
    Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ-CD44 regulates chemotherapy resistance by targeting the miR-330-5p/ABCC1 axis in colorectal cancer cells.
    Zhao S; Xu F; Ji Y; Wang Y; Wei M; Zhang L
    Histol Histopathol; 2023 Feb; 38(2):209-221. PubMed ID: 36106650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer.
    Zhuang YY; Zhong W; Xia ZS; Lin SZ; Chan MC; Jiang K; Li WF; Xu XY
    Cell Death Discov; 2021 Jun; 7(1):129. PubMed ID: 34075026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression.
    Li Y; Liu A; Liu S; Yan L; Yuan Y; Xu Q
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway.
    Zhang Y; Ge T; Xiang P; Zhou J; Tang S; Mao H; Tang Q
    Onco Targets Ther; 2019; 12():9725-9734. PubMed ID: 32009805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway.
    Yin J; Wang L; Wang Y; Shen H; Wang X; Wu L
    Onco Targets Ther; 2019; 12():3893-3903. PubMed ID: 31190888
    [No Abstract]   [Full Text] [Related]  

  • 12. PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway.
    Liu W; Tang J; Gao W; Sun J; Liu G; Zhou J
    Cancer Cell Int; 2024 Mar; 24(1):90. PubMed ID: 38429738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA BCYRN1 exerts an oncogenic role in colorectal cancer by regulating the miR-204-3p/KRAS axis.
    Yang L; Zhang Y; Bao J; Feng JF
    Cancer Cell Int; 2020; 20():453. PubMed ID: 32944001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
    Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
    J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
    Yao H; Lv Y; Bai X; Yu Z; Liu X
    Oncol Lett; 2020 Sep; 20(3):2711-2720. PubMed ID: 32782587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.
    Zhou F; Wang L; Jin K; Wu Y
    Bioengineered; 2021 Dec; 12(1):5859-5869. PubMed ID: 34477047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.